Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

New compositions for controlled release of tolterodine claimed by Ranbaxy

Feb. 7, 2005

Two novel and potent SSRI chemotypes presented by BMS

Feb. 7, 2005

Bristol-Myers Squibb researchers report synthesis of novel SSRI candidate

Feb. 7, 2005

BMS tests potassium channel opener for urinary incontinence therapy

Feb. 7, 2005

Cognition unaffected by darifenacin in elderly subjects

Feb. 3, 2005

Protease-activated receptors implicated in lower urinary tract inflammation

Feb. 3, 2005

Spectrum acquires rights to RenaZorb

Feb. 3, 2005

RDP-58 active in model of interstitial cystitis

Feb. 2, 2005

Lilly withdraws duloxetine NDA for stress urinary incontinence

Feb. 2, 2005

Yamanouchi presents novel series of antidiuretic compounds

Jan. 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...